These include the genes IRF8, CTLA-4, SLAMF8 and others, which are downregulated in DCM as compared to controls–or theoretically vice versa since the controls receive immunosuppressive medication after their heart transplantation. This evidence concerns the gene SLAMF8 and familial dilated cardiomyopathy.